← Back to Patent Explorer
US4455256A Expired / Lapsed US ⏱️ 0.0 years remaining

Bone morphogenetic protein

Assignee: University of California
•
Filing: 1981-05-05
•
Granted: 1984-06-19
•
Expires: 2001-05-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Bone morphogenetic protein (BMP) made by the process comprising the steps of demineralizing bone tissue; treating the demineralized bone tissue under aqueous conditions with a water soluble neutral salt and a solubilizing agent for the BMP, the agent being selected from the group consisting of urea and guanidine, and thereby transforming the bone collagen to gelatin and extracting BMP into the solution of solubilizing agent; and separating the solubilizing agent and neutral salt from the solution, thereby precipitating BMP in the aqueous medium, and the BMP has a molecular weight in the range of 1,000-100,000.

Inventors

  • 👤 Marshall R. Urist

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 04:34
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/14; A61L27/22; A61L27/227; A61F; A61F2/00; A61F2/02; A61F2/28; A61K; A61K35/00; A61K35/12; A61K35/32; C; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/51; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/84; Y10S623/00; Y10S623/915; Y10S623/919

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 98 words
Bone morphogenetic protein (BMP) made by the process comprising the steps of: (a) demineralizing bone tissue; (b) treating said demineralized bone tissue under aqueous conditions with a water soluble neutral salt and a solubilizing agent for said BMP, said agent being selected from the group consisting of urea and guanidine, and thereby transforming the bone collagen to gelatin and extracting BMP into said solution of solubilizing agent; and (c) separating said solubilizing agent and neutral salt from said solution, thereby precipitating BMP in the aqueous medium, and said BMP has a molecular weight in the range of 1,000-100,000.
Claim 2
Dependent Claim 98 words
Bone morphogenetic protein (BMP) made by the process comprising the steps of: (a) demineralizing bone tissue; (b) treating said demineralized bone tissue under aqueous conditions with a water soluble neutral salt and a solubilizing agent for said BMP, said agent being selected from the group consisting of urea and guanidine, and thereby transforming the bone collagen to gelatin and extracting BMP into said solution of solubilizing agent; and (c) separating said solubilizing agent and neutral salt from said solution, thereby precipitating BMP in the aqueous medium, and said BMP has a molecular weight in the range of 1,000-100,000.
Claim 3
Dependent Claim 30 words
The BMP of claim 1, where in said separating step said solubilizing agent and neutral salt are separated from said solution by dialysis thereby precipitating BMP in the aqueous medium.
Claim 4
Dependent Claim 35 words
The BMP of claim 2, including the subsequent step of adding to said BMP precipitate, a solubilizing agent for said BMP precipitate selected from the group consisting of urea and guanidine thereby solubilizing said BMP.
Claim 5
Dependent Claim 28 words
The BMP of claim 3, including the step of washing said BMP precipitate from said dialysis step with citric acid prior to said addition of a solubilizing agent.
Claim 6
Dependent Claim 21 words
The BMP of claim 3, including the subsequent step of coprecipitating BMP and a calcium salt from said solution of BMP.
Claim 7
Dependent Claim 14 words
The BMP of claim 2, wherein said neutral salt is a physiologically acceptable salt.
Claim 8
Dependent Claim 19 words
The BMP of claim 2, wherein said solubilizing agent is urea, and said neutral salt is a chloride salt.
Claim 9
Dependent Claim 12 words
The BMP of claim 7, wherein said neutral salt is calcium chloride.
Claim 10
Dependent Claim 27 words
The BMP of claim 7, wherein said neutral salt is selected from the group consisting of calcium chloride, sodium chloride, potassium chloride, lithium chloride and strontium chloride.
Claim 11
Dependent Claim 13 words
The BMP of claim 3, wherein said subsequently added solubilizing agent is urea.
Claim 12
Dependent Claim 14 words
The BMP of claim 4, including the step of gel filtering said solubilized BMP.
Claim 13
Dependent Claim 26 words
The BMP of claim 11, including the step of recovering a BMP fraction having a molecular weight in the range of between about 1,000 and 100,000.
Claim 14
Dependent Claim 21 words
The BMP of claim 12, wherein said solubilizing agents are urea, and said neutral salt is a physiologically acceptable chloride salt.
Claim 15
Dependent Claim 12 words
The BMP of claim 5, wherein said calcium salt is calcium phosphate.
Claim 16
Dependent Claim 18 words
The BMP of claim 5, wherein each BMP precipitation step is carried out in a low temperature environment.
Claim 17
Dependent Claim 17 words
The BMP of claim 8, wherein said calcium chloride is in a molar solution of about 0.5M.
Claim 18
Dependent Claim 16 words
The BMP of claim 10, wherein said urea is in a molar solution of about 6M.
Claim 19
Dependent Claim 21 words
The BMP of claim 3, wherein said BMP has a molecular weight in the range of between about 20,000 and 63,000.
Claim 20
Dependent Claim 21 words
The BMP of claim 3, wherein said BMP has a molecular weight in the range of between about 10,000 and 63,000.
Claim 21
Dependent Claim 21 words
The BMP of claim 3, wherein said BMP has a molecular weight in the range of between about 20,000 and 50,000.

References Cited (Backward Citations)

US2384673A Cited
US2717835A Cited
US3539549A Cited
US3887717A Cited
US4294753A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-06-19 1987-12-19 1988-06-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-06-19 1991-12-19 1992-06-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-06-19 1995-12-19 1996-06-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag